WASL and lung cancer: This is achieved by examining the activity of nWASP in human lung cancer tissues and by studying the effects of nWASP knockdown and the nWASP inhibitor wiskostatin [24] on lung cancer cell behaviour, with particular focus towards migratory, invasive, adhesive and proliferative properties.